A morphometric study of the cerebellar cortex from patients with carcinoma

Clicks: 133
ID: 116612
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #321 of 438 articles by views in acta neuropathologica

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 438 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
A loss of cells in the cerebellar cortex of autopsy subjects without previous neurologic symptomatology having died with carcinoma has been shown with classical morphometric procedures and automatic measuring techniques. The reduction of the number of Purkinje cells was an overall finding, whereas the loss of granular cells was restricted to a few types of carcinomas. In ovarian carcinoma the Purkinje cell and granular cell loss was most pronounced and their respective values were within the range of systemic cerebellar atrophies. These findings are likely to constitute clinically latent and biologically compensated precursor stages wich under certain conditions go on to a subsequent overt paraneoplastic syndrom.
Reference Key
schmid1970actaa Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors A. H. Schmid;U. N. Riede;A. H. Schmid;U. N. Riede;
Journal acta neuropathologica
Year 1970
DOI
doi:10.1007/BF00685288
URL
https://link.springer.com/article/10.1007/BF00685288
Keywords
pathology neurosciences

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.